Dana-Farber Cancer Biology Department

The science that shaped conversations at #ASCO26 in 60 seconds! Highlights from @DanaFarber are likely to change the standard of care in several cancer types, including pancreatic, prostate, breast, multiple myeloma, and sarcoma. Read more here: bit.ly/4w2jHtz

Ever wonder what makes your heart get stronger with exercise? @SumeetKhetarpal uncovered a gene and secreted factor that make all the difference between the heart getting stronger and actually getting weaker. As always, really elegant work. With @LabSpiegelman and @rosenzweig_a.

Priority member access to housing for #AACR26 ends today. AACR members in good standing have an exclusive opportunity to reserve Annual Meeting hotel rooms until 11:59 PM ET today. Nonmember housing will open on Thursday, September 25. Learn more: brnw.ch/21wW3kS

Congratulations!!!

Nature research paper: Covariation MS uncovers a protein that controls cysteine catabolism go.nature.com/3VoEver

We also provide the resource as an online interface that we hope will be useful to the metabolism community for discovery of proteins that regulate metabolic processes: mpca-chouchani-lab.dfci.harvard.edu

Congratulations Ed!!

New research published in Nature led by @DanaFarber’s @echouchani identifies a protein that regulates the abundance of the metabolite cysteine, a major issue in cancer where numerous tumors rely on this metabolite to survive. Read more: bit.ly/3IhAyp2

Looking to launch an independent research career at the intersection of chemical biology, medicinal chemistry, cancer biology and drug discovery? Look no further - we are hiring! careers.dana-farber.org/job/11813/assi…

Join the @AACR in supporting federal funding of research. Urge your members of Congress to increase funding for the National Institutes of Health. Your voice can help drive a breakthrough. Take action today: brnw.ch/21wU1hm

David Pellman, MD, member of Dana-Farber/@BostonChildrens Cancer and Blood Disorders Center, has been elected as a new Associate (foreign) Member of the European Molecular Biology Organization (@EMBO)—a lifelong honor recognizing excellence in the life sciences. He is one of 69 scientists elected to the 2025 EMBO Membership class. Please join us in congratulating him on this prestigious honor. Learn more: bit.ly/3GvX7Fs

New research in @PNASNews led by @DanaFarber’s Yubao Wang, PhD, in the lab of Tom Roberts, PhD, explored an engineered, degradable form of a small viral protein and made new insights into a key cell growth pathway often hijacked by cancer cells. Read more: bit.ly/4ezpMpE

In collaboration with Beth Israel Deaconess Medical Center, our new dedicated cancer hospital, projected to open in 2031, will strengthen Boston’s position as a global leader in oncology — and expand access to the most advanced care for patients across the region. Learn how we’re raising more than just a hospital – we're raising the standard of cancer care for everyone: bit.ly/402eQej

A new study in @CellPressNews led by @DanaFarber’s @XinGu0317 highlights midnolin as a key regulatory component of proteostasis in plasma cells and suggests that restoring or enhancing this pathway could represent a novel therapeutic avenue in myeloma treatment. Read more: bit.ly/4l8Zuwu

Congratulations Xin!!

Congratulations to @DanaFarber’s @JudithAgudo1 who has been named a 2025 CRI Lloyd J. Old STAR by @CancerResearch for her innovative contributions to the field of cancer immunotherapy.

From today, all new submissions to Nature that are published will be accompanied by referees’ reports and author responses — to illuminate the process of producing rigorous science go.nature.com/44hKo29